These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Relation between citicoline and pulmonary surfactant. Recent acquisitions in the treatment of respiratory syndromes of the newborn]. Colombo ML; Dogliani P; Raggi M Minerva Pediatr; 1976 Nov; 28(37):2303-10. PubMed ID: 1036757 [No Abstract] [Full Text] [Related]
3. [Prenatal prevention of the respiratory syndrome. I. Current status of knowledge]. Meriggi E; Parenti MR Minerva Ginecol; 1980 Mar; 32(3):175-86. PubMed ID: 6103524 [No Abstract] [Full Text] [Related]
4. [Increased production of alveolar surfactant in the human fetus after treatment with cytidine diphosphocholine]. Bracaglia R; Bellati U; Buscemi L; Riccardi P; Garzetti GG; Liverani A Clin Ter; 1977 Dec; 83(5):531-9. PubMed ID: 580231 [No Abstract] [Full Text] [Related]
5. [Surfactant and respiratory distress syndrome]. Renovanz HD; von Seefeld H Prax Klin Pneumol; 1978 Jul; 32(7):443-66. PubMed ID: 28518 [No Abstract] [Full Text] [Related]
6. [The place of citicolin in pulmonological therapy (author's transl)]. Cornia G; Gramiccioni E MMW Munch Med Wochenschr; 1976 Jun; 118(25):817-8. PubMed ID: 819809 [TBL] [Abstract][Full Text] [Related]
7. [Glucocorticoids and the respiratory distress syndrome in the newborn. A review of the literature]. Gandibleux-Bergiers MF J Gynecol Obstet Biol Reprod (Paris); 1982; 11(5):625-37. PubMed ID: 6757311 [TBL] [Abstract][Full Text] [Related]
8. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Liggins GC; Howie RN Pediatrics; 1972 Oct; 50(4):515-25. PubMed ID: 4561295 [No Abstract] [Full Text] [Related]
9. Antepartum prevention of respiratory distress syndrome (hyaline membrane disease). Sahu S J Iowa Med Soc; 1976 Dec; 66(12):481-3, 485-6. PubMed ID: 1036747 [No Abstract] [Full Text] [Related]
10. [Factors increasing susceptibility to neonatal hyaline membrane syndrome and its prevention. I. Deficiency of surfactant and glucocorticoid treatment]. Uszyńska-Folejewska R; Uszyński M Pediatr Pol; 1977 Dec; 52(12):1413-7. PubMed ID: 343058 [No Abstract] [Full Text] [Related]
11. [Respiratory function and alveolar biological changes under the effect of CDP-choline in pulmonary interstitial pathology: pulmonary fibrosis and sarcoidosis]. Pacheco Y; Douss T; Pujol B; Revol A; Vergnon JM; Biot N; Brune J; Perrin-Fayolle M Rev Pneumol Clin; 1985; 41(2):91-100. PubMed ID: 3839593 [TBL] [Abstract][Full Text] [Related]
12. [Drug-induced alteration of the alveolar content of pulmonary surfactant ]. Alcindor LG Arch Fr Pediatr; 1982 May; 39(5):327-33. PubMed ID: 6896976 [TBL] [Abstract][Full Text] [Related]
13. Glucocorticoids and the respiratory distress syndrome. Johnson JW; Beck JC; Haberkern CM Obstet Gynecol Annu; 1984; 13():99-129. PubMed ID: 6371622 [No Abstract] [Full Text] [Related]
14. Respiratory distress syndrome: the preventive use of glucocorticoids. Haller CC; King CR J Kans Med Soc; 1981 Mar; 82(3):98-106. PubMed ID: 6895085 [No Abstract] [Full Text] [Related]
15. [Anti-atelectasis factor (surfactant) and hyaline membrane disease in premature infants]. Saule H Med Klin; 1975 Mar; 70(10):409-15. PubMed ID: 1091827 [No Abstract] [Full Text] [Related]
16. [Controlled study of the administration of CDP-choline to preterm newborn infants with respiratory distress syndrome]. Valls i Soler A; Sanjurjo P; Vázquez Cordero C An Esp Pediatr; 1988 Jun; 28(6):493-6. PubMed ID: 3195851 [TBL] [Abstract][Full Text] [Related]
17. [Alveolar surfactant and experimental diabetes (protective action of citicoline)]. Iozzo A; Cardellino G; Dalmasso F; Garbagni R Arch Sci Med (Torino); 1978; 135(2):181-6. PubMed ID: 581158 [TBL] [Abstract][Full Text] [Related]
18. Fetal lung maturation and the antenatal use of glucocorticoids to prevent the respiratory distress syndrome. Shields JR; Resnik R Obstet Gynecol Surv; 1979 May; 34(5):343-63. PubMed ID: 379720 [No Abstract] [Full Text] [Related]
19. [Position of cyticholine in pneumologic therapy]. Cornia G; Gramiccioni E Minerva Med; 1975 Nov; 66(77):4053-5. PubMed ID: 1041758 [TBL] [Abstract][Full Text] [Related]
20. [Critical study of the use of glucocorticoids in the prevention of hyaline membrane disease]. Leroy JL J Gynecol Obstet Biol Reprod (Paris); 1982; 11(1):152-7. PubMed ID: 6896522 [No Abstract] [Full Text] [Related] [Next] [New Search]